Virbac SA (EPA:VIRP)
352.00
-2.50 (-0.71%)
At close: Mar 20, 2026
Virbac Company Description
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products.
It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Virbac SA

| Country | France |
| Founded | 1968 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 6,365 |
| CEO | Paul Martingell |
Contact Details
Address: 13e rue LID - BP 27 Carros, 06511 France | |
| Phone | 33 4 92 08 71 00 |
| Website | corporate.virbac.com |
Stock Details
| Ticker Symbol | VIRP |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0000031577 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Paul Martingell | Chief Executive Officer |
| Habib Ramdani | Executive Vice President, Deputy Chief Executive Officer and Chief Financial Officer |
| Marc Bistuer | Executive Vice President of Compliance |
| André Mathieu | Executive Vice President of Operations |
| Sandrine Brunel | Head of Corporate Communications |
| Nathalie Pollet | Executive Vice President of Global Marketing and Market Development |
| Francesca Cortella | Executive Vice President of Human Resources |
| Sophie Favini | Executive Vice President of International Region |
| Bertrand Havrileck | Executive Vice President of Research & Development |
| Enguerrand Dubois | Executive Vice President of Europe Region |